BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 38688925)

  • 1. Cost-effectiveness and cost-utility of a digital technology-driven hierarchical healthcare screening pattern in China.
    Wu X; Wu Y; Tu Z; Cao Z; Xu M; Xiang Y; Lin D; Jin L; Zhao L; Zhang Y; Liu Y; Yan P; Hu W; Liu J; Liu L; Wang X; Wang R; Chen J; Xiao W; Shang Y; Xie P; Wang D; Zhang X; Dongye M; Wang C; Ting DSW; Liu Y; Pan R; Lin H
    Nat Commun; 2024 Apr; 15(1):3650. PubMed ID: 38688925
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Economic evaluation of combined population-based screening for multiple blindness-causing eye diseases in China: a cost-effectiveness analysis.
    Liu H; Li R; Zhang Y; Zhang K; Yusufu M; Liu Y; Mou D; Chen X; Tian J; Li H; Fan S; Tang J; Wang N
    Lancet Glob Health; 2023 Mar; 11(3):e456-e465. PubMed ID: 36702141
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Artificial Intelligence in Community-Based Diabetic Retinopathy Telemedicine Screening in Urban China: Cost-effectiveness and Cost-Utility Analyses With Real-world Data.
    Lin S; Ma Y; Xu Y; Lu L; He J; Zhu J; Peng Y; Yu T; Congdon N; Zou H
    JMIR Public Health Surveill; 2023 Feb; 9():e41624. PubMed ID: 36821353
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cost-effectiveness and cost-utility of traditional and telemedicine combined population-based age-related macular degeneration and diabetic retinopathy screening in rural and urban China.
    Li R; Yang Z; Zhang Y; Bai W; Du Y; Sun R; Tang J; Wang N; Liu H
    Lancet Reg Health West Pac; 2022 Jun; 23():100435. PubMed ID: 35355615
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cost-effectiveness analysis of artificial intelligence-based diabetic retinopathy screening in rural China based on the Markov model.
    Li H; Li G; Li N; Liu C; Yuan Z; Gao Q; Hao S; Fan S; Yang J
    PLoS One; 2023; 18(11):e0291390. PubMed ID: 37971984
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cost-effectiveness and cost-utility of population-based glaucoma screening in China: a decision-analytic Markov model.
    Tang J; Liang Y; O'Neill C; Kee F; Jiang J; Congdon N
    Lancet Glob Health; 2019 Jul; 7(7):e968-e978. PubMed ID: 31122906
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cost-effectiveness of artificial intelligence screening for diabetic retinopathy in rural China.
    Huang XM; Yang BF; Zheng WL; Liu Q; Xiao F; Ouyang PW; Li MJ; Li XY; Meng J; Zhang TT; Cui YH; Pan HW
    BMC Health Serv Res; 2022 Feb; 22(1):260. PubMed ID: 35216586
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Health care cost and benefits of artificial intelligence-assisted population-based glaucoma screening for the elderly in remote areas of China: a cost-offset analysis.
    Xiao X; Xue L; Ye L; Li H; He Y
    BMC Public Health; 2021 Jun; 21(1):1065. PubMed ID: 34088286
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The cost-utility of telemedicine to screen for diabetic retinopathy in India.
    Rachapelle S; Legood R; Alavi Y; Lindfield R; Sharma T; Kuper H; Polack S
    Ophthalmology; 2013 Mar; 120(3):566-573. PubMed ID: 23211635
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cost-effectiveness of Artificial Intelligence-Based Retinopathy of Prematurity Screening.
    Morrison SL; Dukhovny D; Chan RVP; Chiang MF; Campbell JP
    JAMA Ophthalmol; 2022 Apr; 140(4):401-409. PubMed ID: 35297945
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effectiveness and health economic analysis of strategies on cervical cancer screening and early diagnosis and treatment].
    Zhao FH; Chen JF; Gao XH; Gao LM; Liu QG; Liu ZH; Xu H; Ma JF; Ma L; Xu XL; Hu SY; Ning Y; Shi JF; Qiao YL
    Zhonghua Zhong Liu Za Zhi; 2012 Aug; 34(8):632-6. PubMed ID: 23159002
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Economic evaluation of fifteen cervical cancer screening strategies in rural China].
    Wang YY; Wang ZJ; Zhang Y; Gao XH; Yang CX; Zhao FH; Qiao YL; Ma L; Lang JH
    Zhonghua Fu Chan Ke Za Zhi; 2019 Dec; 54(12):840-847. PubMed ID: 31874474
    [No Abstract]   [Full Text] [Related]  

  • 13. Cost-effectiveness of universal screening for chronic hepatitis B virus infection in China: an economic evaluation.
    Su S; Wong WC; Zou Z; Cheng DD; Ong JJ; Chan P; Ji F; Yuen MF; Zhuang G; Seto WK; Zhang L
    Lancet Glob Health; 2022 Feb; 10(2):e278-e287. PubMed ID: 35063115
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Implementing a digital comprehensive myopia prevention and control strategy for children and adolescents in China: a cost-effectiveness analysis.
    Li R; Zhang K; Li SM; Zhang Y; Tian J; Lu Z; Li H; Wang L; Wan X; Zhang F; Li L; Jin ZB; Wang N; Liu H
    Lancet Reg Health West Pac; 2023 Sep; 38():100837. PubMed ID: 37520278
    [TBL] [Abstract][Full Text] [Related]  

  • 15. DrishtiCare: a telescreening platform for diabetic retinopathy powered with fundus image analysis.
    Joshi GD; Sivaswamy J
    J Diabetes Sci Technol; 2011 Jan; 5(1):23-31. PubMed ID: 21303621
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of vaccination age on cost-effectiveness of human papillomavirus vaccination against cervical cancer in China.
    Liu YJ; Zhang Q; Hu SY; Zhao FH
    BMC Cancer; 2016 Feb; 16():164. PubMed ID: 26919850
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cost Effectiveness of an Electrocardiographic Deep Learning Algorithm to Detect Asymptomatic Left Ventricular Dysfunction.
    Tseng AS; Thao V; Borah BJ; Attia IZ; Medina Inojosa J; Kapa S; Carter RE; Friedman PA; Lopez-Jimenez F; Yao X; Noseworthy PA
    Mayo Clin Proc; 2021 Jul; 96(7):1835-1844. PubMed ID: 34116837
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cost-effectiveness of a National Telemedicine Diabetic Retinopathy Screening Program in Singapore.
    Nguyen HV; Tan GS; Tapp RJ; Mital S; Ting DS; Wong HT; Tan CS; Laude A; Tai ES; Tan NC; Finkelstein EA; Wong TY; Lamoureux EL
    Ophthalmology; 2016 Dec; 123(12):2571-2580. PubMed ID: 27726962
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cost-effectiveness of using artificial intelligence versus polygenic risk score to guide breast cancer screening.
    Mital S; Nguyen HV
    BMC Cancer; 2022 May; 22(1):501. PubMed ID: 35524200
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cost-effectiveness of artificial intelligence for screening colonoscopy: a modelling study.
    Areia M; Mori Y; Correale L; Repici A; Bretthauer M; Sharma P; Taveira F; Spadaccini M; Antonelli G; Ebigbo A; Kudo SE; Arribas J; Barua I; Kaminski MF; Messmann H; Rex DK; Dinis-Ribeiro M; Hassan C
    Lancet Digit Health; 2022 Jun; 4(6):e436-e444. PubMed ID: 35430151
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.